Insulet’s technology perspective: past, present and future


  • Severine Liabat Insulet France



automated insulin delivery, tubeless insulin pump therapy, innovation


Ly TT, Layne JE, Huyett LM, Nazzaro D, O’Connor JB. Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age. J Diabetes Sci Technol 2019;13(1):20-26.

Pillalamarri SS, Huyett LM, Abdel-Malek A. Novel Bluetooth-Enabled Tube- less Insulin Pump: A User Experience Design Approach for a Connected Digital Diabetes Management Platform. J Diabetes Sci Technol 2018; 12(6):1132-42.

Aleppo G, DeSalvo DJ, Lauand F, et al. Glycemic Improvement in 11,273 Adults with Type 1 Diabetes (T1D) Using the Omnipod® Insulin Manage- ment System Over First 90 Days of Use. Diabetes 2021;70(S1):698-P.

DeSalvo DJ, Aleppo G, Lauand F, et al. Glycemic Improvement in 5,094 Pediatric Patients with Type 1 Diabetes (T1D) Using the Omnipod® Insulin Management System Over First 90 Days of Use. Diabetes 2021;70(S1):702-P.

Beck RW, Riddlesworth TD, Ruedy KJ, et al. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin in- jections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 2017;5:700-08.

Polonsky WH, Hessler D, Layne JE, Zisser H. Impact of the Omnipod® In- sulin Management System on Quality of Life: A Survey of Current Users. Diabetes Technol Ther 2016;18(10):664-670.

Biester T, Schwandt A, Heidtmann B, et al. Declining Frequency of Acute Complications associated with Tubeless Insulin Pump Use: Data from 2,911 Patients in the German/Austrian DPV Registry. Diabetes Technol Ther 2021;23(8):527-36.

Brown RE, Vienneau T, Aronson R. Canadian Real-World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): Evi- dence from the LMC Diabetes Registry. Diabet Med 2020;38(6):e14420.

Mehta SN, Tinsley LJ, Kruger D, et al. Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes. Clin Diabetes 2021;39(1):72-9.

Brown SA, Forlenza GP, Bode BW, et al. Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System with Customizable Glycemic Targets in Pediatric and Adult Participants with Type 1 Diabetes. Diabetes Care 2021;44(7):1630-40.

Sherr JL, Bode BW, Forlenza GP, et al, Omnipod 5 in Preschoolers Study Group. Safety and Efficacy of a Tubeless Automated Insulin Delivery System in Very Young Children with Type 1 Diabetes: A Multicenter Clinical Trial. Diabetes Care 2022;45(8):1907-10.